Related references
Note: Only part of the references are listed.High levels of serum platelet-derived growth factor-AA and human epidermal growth factor receptor-2 are predictors of colorectal cancer liver metastasis
Hong-Da Pan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Quantitative Measurement of the Target-Mediated Internalization Kinetics of Biopharmaceuticals
Inna Vainshtein et al.
PHARMACEUTICAL RESEARCH (2015)
A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors
Carlos R. Becerra et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indicates poor prognosis in hepatocellular carcinoma
Tao Wei et al.
ONCOTARGET (2014)
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
George D. Demetri et al.
LANCET (2013)
An open-label, single-dose bioavailability study of the pharmacokinetics of CAT-354 after subcutaneous and intravenous administration in healthy males
Chad K. Oh et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
O. Martinho et al.
BRITISH JOURNAL OF CANCER (2009)
Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
F. J. Giles et al.
LEUKEMIA (2009)
Drug Insight: gastrointestinal stromal tumors (GIST) - the solid tumor model for cancer-specific treatment
Stefan Sleijfer et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRα-positive hypereosinophilic syndrome. Results of a multicenter prospective study
Michele Baccarani et al.
HAEMATOLOGICA (2007)
Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure
Alfonso Quintas-Cardama et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Antagonism of platelet-derived growth factor receptor in non-small cell lung cancer: Rationale and investigations
Julie E. Bauman et al.
CLINICAL CANCER RESEARCH (2007)
Phase I trial of intermittent administration of sorafenib (BAY 43-9006) for patients (pts) with refractory/relapsed acute myelogenous leukemia (AML)
A. Quintas-Cardama et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Molecular basis for sunitinib efficacy and future clinical development
Sandrine Faivre et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume
GC Jayson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Biology of gastrointestinal stromal tumors
CL Corless et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma
A Östman
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Share Paper
